Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Target Price
The average target price of UBM.MI is 1.4 and suggests 71% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell